Cernostics lands $2.5 mln
Pennsylvania-based Cernostics, a provider of next-generation cancer diagnostics and prognostics, has raised $2.5 million in Series A1 financing. Illumina Ventures led the round.
21 March 2018•1 min read
Pennsylvania-based Cernostics, a provider of next-generation cancer diagnostics and prognostics, has raised $2.5 million in Series A1 financing. Illumina Ventures led the round.
